{reportSlug=global-endometriosis-therapies-market, reportId=63303, mktKeyword=Endometriosis Therapies, cagr=0.00, publishDate=Jan 2024, priceOption2=7500, reportTitle=Endometriosis Therapies Comprehensive Study by Type (Hormonal Therapy (Oral Contraceptive Pills, Progestins), Hormone Replacement Therapy (GnRH Agonists, Luteinizing-hormone-releasing hormone receptor antagonist, etc.), Aromatase Inhibitors, Thermal Endometrial Ablation Devices), Application (Hospital, Clinic, Other), Drug Type (Oral Contraceptives, Progestins, NSAIDs, GnRH Analogues, LNR-IUDs, Others), Synthetic Hormone (Danazol, Gestrinone), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, E-commerce), Surgery (Laparoscopy, Hysterectomy, Laparotomy), Treatment Type (Pain Management, Hormone Therapy) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=163, priceOption1=3750, forecastYr=2030, noOfPages=221, reportKey=62980, breadcrum=Global Endometriosis Therapies Market}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Jan 2024 221 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner